Disposition of 9926 shares by Jean Holloway of Artivion at 29.0 subject to Rule 16b-3
| AORT Stock | USD 32.15 0.09 0.28% |
Slightly above 53% of Artivion's investor base is interested to short. The analysis of overall sentiment of trading Artivion stock suggests that many investors are impartial at this time. Artivion's investing sentiment can be driven by a variety of factors including economic data, Artivion's earnings reports, geopolitical events, and overall market trends.
Filed transaction by Artivion Officer: Svp, General Counsel. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Artivion Fundamental Analysis
We analyze Artivion's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Artivion using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Artivion based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Artivion is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Artivion Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Artivion stock to make a market-neutral strategy. Peer analysis of Artivion could also be used in its relative valuation, which is a method of valuing Artivion by comparing valuation metrics with similar companies.
Peers
Artivion Related Equities
| OFIX | Orthofix Medical | 13.46 | ||||
| AVNS | Avanos Medical | 2.46 | ||||
| CTKB | Cytek Biosciences | 1.04 | ||||
| TMCI | Treace Medical | 0.36 | ||||
| AXGN | Axogen | 0.95 | ||||
| SRDX | SurModics | 1.11 | ||||
| ANIK | Anika Therapeutics | 4.79 | ||||
| MODV | ModivCare | 7.17 |
Additional Tools for Artivion Stock Analysis
When running Artivion's price analysis, check to measure Artivion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Artivion is operating at the current time. Most of Artivion's value examination focuses on studying past and present price action to predict the probability of Artivion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Artivion's price. Additionally, you may evaluate how the addition of Artivion to your portfolios can decrease your overall portfolio volatility.